Ercros, S.A. Reports Consolidated Earnings Results for the Year Ended December 31, 2019; Provides Sales Guidance for the Year 2020
February 28, 2020 at 04:37 pm EST
Share
Ercros, S.A. reported consolidated earnings results for the year ended December 31, 2019. The income generated by Ercros in 2019 amounted to EUR 689.1 million, up EUR 4.3 million on the previous year, representing growth of 0.6%; accordingly, expenses amounted to EUR 628.2 million, up EUR 14.5 million on 2018, equal to an increase of 2.4%. This gave rise to a Profit for 2019 amounted to EUR 31 million, 30.4% less than the EUR 44.6 million obtained in 2018. Earnings per share were EUR 0.2924 compared to EUR 0.4085 in 2018. Ebit was EUR 28.713 million against EUR 44.747 million a year ago.
The company is therefore moderately optimistic about a possible improvement in margins throughout 2020, which should be achieved by an increase in sales, a greater volume of products sold, maintaining low prices in the main raw materials and reducing energy costs.
Ercros SA is a Spain-based company engaged, together with its subsidiaries, in the chemical industry. The Companyâs products are structured into three business lines: Businesses Associated to Chlorine, which comprises the production of chlorine, ethyl acetate, caustic soda, sodium hypochlorite, dichloroethane, chloromethane, sodium chlorate and caustic potash, polyvinyl chloride (PCV), as well as water disinfectants; Intermediate Chemicals, which produces formaldehyde, glues and resins for the fiberboard and plywood industries, and Pharmaceuticals, which comprises raw material and intermediate products used in the pharmaceutical industry. The Company owns such subsidiaries as Marcoating SLU, Gades Ltd and Ercekol AIE, among others. In April 2014, it sold Fosfatos de Cartagena SLU to Timab Iberica.
ERCROS, S.A. 
